Search results
Results from the WOW.Com Content Network
Dextromethorphan, sold under the brand name Robitussin among others, is a cough suppressant used in many cough and cold medicines. [6] In 2022, the US Food and Drug Administration (FDA) approved the combination dextromethorphan/bupropion to serve as a rapid-acting antidepressant in people with major depressive disorder.
Cough medicine containing dextromethorphan in tablet form (15mg) Dextromethorphan , or DXM , a common active ingredient found in many over-the-counter cough suppressant cold medicines, is used as a recreational drug and entheogen for its dissociative effects. [ 1 ]
This bill provided that any infraction of a provider in an over-the-counter sale who willfully and knowingly supply, deliver, or give possession of a non-prescription drug that contains dextromethorphan to a person under the age of 18 would incur a fine of $250.The bill also mentions that proof that identification at the time of purchase was ...
The LiquiCap capsule version has the following active ingredients per pill, half the recommended adult dose: Acetaminophen (325 mg/pill) (pain reliever/fever reducer) Dextromethorphan (15 mg/pill) (cough suppressant) Doxylamine succinate (6.25 mg/pill) (antihistamine/hypnotic) Phenylephrine (5 mg/pill) (nasal decongestant)
Coricidin, Coricidin 'D' (decongestant), or Coricidin HBP (for high blood pressure), is the name of an over-the-counter cough and cold drug containing dextromethorphan (a cough suppressant) and chlorpheniramine maleate (an antihistamine). [1] Introduced by Schering-Plough in 1949 as one of the first antihistamines, it is now owned by Bayer.
For premium support please call: 800-290-4726 more ways to reach us
Cough medicines, especially those containing dextromethorphan and codeine, are often abused as recreational drugs. [ 30 ] [ 31 ] Abuse may result in hallucinations, loss of consciousness and death. Many cough syrups can contain acetaminophen which will cause liver damage in recreational users.
(Reuters) -The U.S. Food and Drug Administration (FDA) declined to approve Merck's drug for chronic cough, the company said on Wednesday, marking the second rejection in less than two years.